.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
Johnson and Johnson
Novartis
Chinese Patent Office
UBS
Baxter
Cantor Fitzgerald
Queensland Health
Dow

Generated: November 21, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN GLULISINE RECOMBINANT

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis Us
APIDRA
insulin glulisine recombinant
INJECTABLE;IV (INFUSION), SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2500-3310 mL in 1 VIAL, GLASS (0088-2500-33)
Sanofi Aventis Us
APIDRA
insulin glulisine recombinant
INJECTABLE;IV (INFUSION), SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2502-055 SYRINGE, PLASTIC in 1 PACKAGE (0088-2502-05) > 3 mL in 1 SYRINGE, PLASTIC
Sanofi Aventis Us
APIDRA SOLOSTAR
insulin glulisine recombinant
INJECTABLE;SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2500-3310 mL in 1 VIAL, GLASS (0088-2500-33)
Sanofi Aventis Us
APIDRA SOLOSTAR
insulin glulisine recombinant
INJECTABLE;SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2502-055 SYRINGE, PLASTIC in 1 PACKAGE (0088-2502-05) > 3 mL in 1 SYRINGE, PLASTIC
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
QuintilesIMS
McKesson
McKinsey
Mallinckrodt
Julphar
Federal Trade Commission
AstraZeneca
Citi
Dow

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot